Assessment of handgrip strength as a predictor of 6-month mortality in Egyptian patients with liver cirrhosis.

Assessment of Handgrip Strength as a Predictor of 6-Month Mortality in Egyptian Patients with Liver Cirrhosis.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202607879846843

Enrollment

Registered

2026-07-10

Start date

2025-10-05

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System

Interventions

Handgrip strength assessment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Confirmed diagnosis of liver cirrhosis based on clinical, laboratory, radiological, and/or histological evidence. - Able and willing to provide written informed consent. - Available for 6-month mortality follow-up.

Exclusion criteria

Exclusion criteria: - Pre-existing neuromuscular disorders affecting muscle strength. - Upper-limb injury or disability interfering with handgrip strength assessment. - History of liver transplantation. - Inability to provide informed consent. - Missing baseline handgrip strength measurement or unavailable mortality follow-up

Design outcomes

Primary

Measure	Time frame
All-cause mortality within 6 months after baseline handgrip	—

Secondary

Measure	Time frame
Occurrence of liver-related decompensation events, including ascites, variceal bleeding, and hepatic encephalopathy, during follow-up.	—

Countries

Egypt

Contacts

Public ContactElsayedamr Basma

Patient Information Manager

elsayedamr@yahoo.com00201223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026